PROCTER & GAMBLE HEALTH | TYCHE INDUSTRIES | PROCTER & GAMBLE HEALTH/ TYCHE INDUSTRIES |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 34.6 | 15.8 | 218.8% | View Chart |
P/BV | x | 10.6 | 1.9 | 547.1% | View Chart |
Dividend Yield | % | 2.0 | 0.9 | 220.9% |
PROCTER & GAMBLE HEALTH TYCHE INDUSTRIES |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
PROCTER & GAMBLE HEALTH Jun-23 |
TYCHE INDUSTRIES Mar-23 |
PROCTER & GAMBLE HEALTH/ TYCHE INDUSTRIES |
5-Yr Chart Click to enlarge
|
||
High | Rs | 5,366 | 163 | 3,295.8% | |
Low | Rs | 3,883 | 105 | 3,698.1% | |
Sales per share (Unadj.) | Rs | 740.7 | 73.5 | 1,007.2% | |
Earnings per share (Unadj.) | Rs | 138.2 | 13.8 | 999.8% | |
Cash flow per share (Unadj.) | Rs | 155.2 | 15.6 | 997.4% | |
Dividends per share (Unadj.) | Rs | 95.00 | 2.00 | 4,750.0% | |
Avg Dividend yield | % | 2.1 | 1.5 | 137.5% | |
Book value per share (Unadj.) | Rs | 447.6 | 113.9 | 393.0% | |
Shares outstanding (eoy) | m | 16.60 | 10.25 | 162.0% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 6.2 | 1.8 | 342.9% | |
Avg P/E ratio | x | 33.5 | 9.7 | 345.4% | |
P/CF ratio (eoy) | x | 29.8 | 8.6 | 346.2% | |
Price / Book Value ratio | x | 10.3 | 1.2 | 878.8% | |
Dividend payout | % | 68.7 | 14.5 | 475.1% | |
Avg Mkt Cap | Rs m | 76,761 | 1,372 | 5,592.9% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 2,062 | 70 | 2,963.5% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 12,296 | 754 | 1,631.1% | |
Other income | Rs m | 184 | 48 | 380.9% | |
Total revenues | Rs m | 12,480 | 802 | 1,555.9% | |
Gross profit | Rs m | 3,247 | 160 | 2,025.3% | |
Depreciation | Rs m | 281 | 18 | 1,584.9% | |
Interest | Rs m | 8 | 0 | 77,000.0% | |
Profit before tax | Rs m | 3,142 | 191 | 1,646.4% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 847 | 49 | 1,724.6% | |
Profit after tax | Rs m | 2,295 | 142 | 1,619.2% | |
Gross profit margin | % | 26.4 | 21.3 | 124.2% | |
Effective tax rate | % | 27.0 | 25.7 | 104.8% | |
Net profit margin | % | 18.7 | 18.8 | 99.3% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 11,713 | 1,219 | 960.8% | |
Current liabilities | Rs m | 6,791 | 210 | 3,237.7% | |
Net working cap to sales | % | 40.0 | 133.9 | 29.9% | |
Current ratio | x | 1.7 | 5.8 | 29.7% | |
Inventory Days | Days | 263 | 13 | 2,090.5% | |
Debtors Days | Days | 343 | 1,069 | 32.1% | |
Net fixed assets | Rs m | 10,617 | 192 | 5,527.6% | |
Share capital | Rs m | 166 | 102 | 162.0% | |
"Free" reserves | Rs m | 7,265 | 1,065 | 682.1% | |
Net worth | Rs m | 7,431 | 1,168 | 636.4% | |
Long term debt | Rs m | 0 | 0 | - | |
Total assets | Rs m | 22,330 | 1,411 | 1,582.3% | |
Interest coverage | x | 409.1 | 19,085.0 | 2.1% | |
Debt to equity ratio | x | 0 | 0 | - | |
Sales to assets ratio | x | 0.6 | 0.5 | 103.1% | |
Return on assets | % | 10.3 | 10.0 | 102.7% | |
Return on equity | % | 30.9 | 12.1 | 254.4% | |
Return on capital | % | 42.4 | 16.3 | 259.3% | |
Exports to sales | % | 0 | 57.9 | 0.0% | |
Imports to sales | % | 13.1 | 19.9 | 65.7% | |
Exports (fob) | Rs m | NA | 437 | 0.0% | |
Imports (cif) | Rs m | 1,605 | 150 | 1,071.2% | |
Fx inflow | Rs m | 1,465 | 437 | 335.6% | |
Fx outflow | Rs m | 1,605 | 161 | 994.7% | |
Net fx | Rs m | -140 | 275 | -50.9% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 2,360 | 68 | 3,459.4% | |
From Investments | Rs m | -215 | 19 | -1,107.1% | |
From Financial Activity | Rs m | -985 | -15 | 6,410.8% | |
Net Cashflow | Rs m | 1,160 | 72 | 1,605.3% |
Indian Promoters | % | 0.0 | 62.0 | - | |
Foreign collaborators | % | 51.8 | 0.0 | - | |
Indian inst/Mut Fund | % | 20.0 | 0.0 | - | |
FIIs | % | 6.2 | 0.0 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 48.2 | 38.0 | 126.7% | |
Shareholders | 56,778 | 7,867 | 721.7% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare PROCTER & GAMBLE HEALTH With: DIVIS LABORATORIES CIPLA SUN PHARMA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | Procter & Gamble Health | TYCHE INDUSTRIES | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | -0.43% | 1.27% | 0.45% |
1-Month | -1.15% | 20.94% | 2.55% |
1-Year | 0.73% | 21.95% | 56.14% |
3-Year CAGR | -8.76% | -2.70% | 15.22% |
5-Year CAGR | 4.97% | 26.63% | 19.63% |
* Compound Annual Growth Rate
Here are more details on the Procter & Gamble Health share price and the TYCHE INDUSTRIES share price.
Moving on to shareholding structures...
The promoters of Procter & Gamble Health hold a 51.8% stake in the company. In case of TYCHE INDUSTRIES the stake stands at 62.0%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Procter & Gamble Health and the shareholding pattern of TYCHE INDUSTRIES.
Finally, a word on dividends...
In the most recent financial year, Procter & Gamble Health paid a dividend of Rs 95.0 per share. This amounted to a Dividend Payout ratio of 68.7%.
TYCHE INDUSTRIES paid Rs 2.0, and its dividend payout ratio stood at 14.5%.
You may visit here to review the dividend history of Procter & Gamble Health, and the dividend history of TYCHE INDUSTRIES.
For a sector overview, read our pharmaceuticals sector report.
After opening the day on high, Indian share markets reversed the trend as the session progressed and ended the lower.